Annotated Medicine and Device Lists
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 20. MUSCLE RELAXANTS (PERIPHERALLY-ACTING) AND CHOLINESTERASE INHIBITORS |
This medicine has the best evidence for effectiveness and safety. |
| Peru | 20.1 Peripherally Acting Cholinesterase Inhibitors and Muscle Relaxants | No observations |
| Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020 | 03 RELAJANTES MUSCULARES | No observations |
| Costa Rica. Caja Costarricense de Seguro Social. 2019 | 20. Relajantes musculares | No observations |
| Paraguay. Lista de Medicamentos Esenciales. 2009 | 03. RELAJANTES MUSCULARES | No observations |
| Chile. Formulario Nacional de Medicamentos. 2005 | 01.04. RELAJANTES MUSCULARES | No observations |
| Haiti. National List of Essential Medicines | 20. Muscle Relaxants (Peripheral) and Cholinesterase Inhibitors | No observations |
| List | Section | Observation |
|---|---|---|
| Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. | CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. |
Others observations: X 1 AMP X 3 ML |
| List | Section | Observation |
|---|---|---|
| Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 | 17.01. BLOQUEANTES NEUROMUSCULARES | No observations |